TY - JOUR
T1 - Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific
T2 - Insights from the COVID-19 Pandemic
AU - Woodward, Michael
AU - Ramasubramanian, Venkatasubramanian
AU - Kamarulzaman, Adeeba
AU - Tantawichien, Terapong
AU - Wang, Minggui
AU - Song, Joon Young
AU - Choi, Won Suk
AU - Djauzi, Samsuridjal
AU - Solante, Rontgene
AU - Lee, Wen Sen
AU - Tateda, Kazuhiko
AU - Pan, Hongxing
AU - Wang, Ning Chi
AU - Pang, Tikki
N1 - Funding Information:
An Asia-Pacific regional meeting on the topic ‘Optimising Vaccine Utilisation in Older Adults in Asia-Pacific’, convened by Janssen Pharmaceuticals was a springboard for subsequent manuscript development by all authors. Editorial and medical writing support was provided by Transform Medical Communications, which was funded by Janssen Pharmaceuticals Asia Pacific. The authors sincerely appreciate the medical writing support provided by Dr Sajita Setia, Executive Director, Transform Medical Communications, Auckland, New Zealand, and Dr Veena Angle, Singapore, on behalf of Transform Medical Communications.
Funding Information:
Immunisation programs are financed through the National Vaccination Fund.
Funding Information:
Yes, funded by the government.
Publisher Copyright:
© 2023 Woodward et al.
PY - 2023
Y1 - 2023
N2 - The impact of vaccinating the older population against vaccine-preventable diseases in terms of health, social and economic benefits has been increasingly recognised. However, there is a gap in the utilisation of vaccines worldwide. The population is ageing at an unprecedented pace in the Asia-Pacific (APAC) region, with the number of persons older than 65 years set to double by 2050 to around 1.3 billion. More than 18% of the population in Japan, Hong Kong, and China is over the age of 65 years. This highlights the importance of prioritising resources to address societal obligations toward the needs of the ageing generation. This review provides an overview of the challenges to adult vaccination in APAC, drivers to increase vaccination coverage, vaccination insights gained through the COVID-19 pandemic, and potential measures to increase the uptake of adult vaccines in the region.
AB - The impact of vaccinating the older population against vaccine-preventable diseases in terms of health, social and economic benefits has been increasingly recognised. However, there is a gap in the utilisation of vaccines worldwide. The population is ageing at an unprecedented pace in the Asia-Pacific (APAC) region, with the number of persons older than 65 years set to double by 2050 to around 1.3 billion. More than 18% of the population in Japan, Hong Kong, and China is over the age of 65 years. This highlights the importance of prioritising resources to address societal obligations toward the needs of the ageing generation. This review provides an overview of the challenges to adult vaccination in APAC, drivers to increase vaccination coverage, vaccination insights gained through the COVID-19 pandemic, and potential measures to increase the uptake of adult vaccines in the region.
KW - adult vaccination
KW - adult vaccines
KW - COVID-19 vaccination
KW - vaccine-preventable diseases
KW - VPD
UR - http://www.scopus.com/inward/record.url?scp=85161600389&partnerID=8YFLogxK
U2 - 10.2147/CIA.S406601
DO - 10.2147/CIA.S406601
M3 - Review Article
C2 - 37284594
AN - SCOPUS:85161600389
SN - 1176-9092
VL - 18
SP - 869
EP - 880
JO - Clinical Interventions in Aging
JF - Clinical Interventions in Aging
ER -
